ArticleArchives of osteoporosis2026

The impact of DXA findings on general practitioners' decision regarding first-line oral bisphosphonates in postmenopausal osteoporosis-data from French General Practice (the IMOGENE study).

Bernard Cortet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.